Synageva BioPharma Corp. (NASDAQ:GEVA)

CAPS Rating: 1 out of 5

Results 1 - 2 of 2

Recs

0
Member Avatar trackjakeambrose (67.58) Submitted: 1/1/2013 2:05:16 AM : Underperform Start Price: $47.46 GEVA Score: +33.30

idea from zz, quick look, in every sense this looks like its about to dive for 60% if not more

Report this Post Reply

Recs

1
Member Avatar IBDContrarian (20.82) Submitted: 7/23/2012 1:45:33 PM : Underperform Start Price: $49.14 GEVA Score: +44.81

IBD EPS, RS, SPROE, Acc ratings plus P/E and div yield
MED 3 99 ..A NEG

Name: SyngvBioPh

Report this Post 1 Reply
Results 1 - 2 of 2

Featured Broker Partners


Advertisement